DOCK4 and breast carcinoma: Conversely, another study indicated that LncRNA AC073284.4 can inhibit epithelial-mesenchymal transition (EMT) and reduce migration in breast cancer cells by influencing the miR-18b-5p/DOCK4 axis [19].